The company's co-founder, Andrew To, graduated from Harvard University and is based in the field of life science research. He is engaged in immunological DNA research at Harvard University, focusing on human neutrophil and DNA viability and longevity, and has authoritative scientific experimental results. The company has the world's top R&D team and technology, focusing on anti-aging and health-related research.

The company's product, NMN, known as β-Nicotinamide Mononucleotide (NMN for short), is found in some fruits and vegetables and poultry meat, and is a naturally occurring substance in the human body, which can be converted into NAD+, an important coenzyme related to human metabolism. Studies have confirmed that intracellular NAD+ levels decrease with age, and exogenous supplementation of NMN is thought to have a role in strengthening cellular function. Studies have found that NAD+ levels steadily decay with age, leading to altered metabolism and increased disease susceptibility; restoring NAD+ levels in aged or diseased animals promotes health and extends lifespan.

Beta Bio's NMN is successfully extracted through cutting-edge fermentation enzyme extraction technology with a purity of 99.9% or more. The quality of the product has been certified and passed by several testing institutions, making it a safe and effective dietary supplement.

In today's human development, we are more and more concerned about the quality of life. Young, healthy, that is, our most important research topic.